MDxHealth plans IPO in the United States

MDxHealth plans Initial Public Offering in the United States

HERSTAL, BELGIUM: MDxHealth SA, a commercial-stage precision diagnostics company, is launching a registered initial public offering (IPO) of 3.75 million American Depositary Shares (ADS), each representing 10 ordinary shares of the company with no nominal value per share.

In connection with the Offering, MDxHealth intends to grant the underwriters a 30-day option to purchase additional ordinary shares, which may be in the form of ADSs, in an aggregate amount of up to 15% of the total number of ordinary shares (as the case may be, in the form of ADSs) offered in the Offering on the same terms and conditions.

The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering, including the price per ADS and number of ADSs sold in the Offering.

MDxHealth’s ordinary shares are currently listed on Euronext Brussels under the symbol “MDXH”. An application has been made to list the ADSs on the Nasdaq Capital Market under the same symbol.

Piper Sandler and Oppenheimer & Co. Inc. are acting as lead book-running managers, BTIG is acting as a lead manager, and KBC Securities USA is acting as a co-manager for the Offering.

Leave a Reply

Your email address will not be published. Required fields are marked *